This is a StreetInsider.com Premium Only Page

Kindred Biosciences (KIN) – Press Releases

Oct 24, 2022 09:00 AM TCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of Directors

Aug 10, 2021 02:59 PM SHAREHOLDER ALERT: WeissLaw LLP Reminds SQ, TBIO, KIN, and MNR Shareholders About Its Ongoing Investigations

Jun 23, 2021 12:01 PM SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, FMBI, SLCT, and CNST Shareholders About Its Ongoing Investigations

Jun 16, 2021 12:14 PM SHAREHOLDER ALERT: WeissLaw LLP Investigates Kindred Biosciences, Inc.

Jun 16, 2021 11:41 AM KINDRED BIOSCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of KIN and Encourages Investors to Contact the Firm

Jun 16, 2021 06:30 AM Elanco Announces Agreement to Acquire Kindred Biosciences

Jun 16, 2021 06:30 AM Elanco Announces Agreement to Acquire Kindred Biosciences

Jun 2, 2021 08:31 AM Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

May 25, 2021 08:42 AM Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI

May 11, 2021 04:03 PM Kindred Biosciences Announces First Quarter 2021 Financial Results

May 3, 2021 08:42 AM Kindred Biosciences to Announce First Quarter 2021 Financial Results

Apr 28, 2021 08:32 AM Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication

Apr 26, 2021 08:30 AM TCW Special Purpose Acquisition Corp. Announces Appointment of Nanxi Liu to Advisory Board

Apr 20, 2021 04:03 PM Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study

Mar 16, 2021 04:02 PM Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results

Mar 8, 2021 08:32 AM Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results

Mar 2, 2021 08:31 AM Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference

Feb 25, 2021 08:01 AM Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication

Feb 16, 2021 04:02 PM Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit

Feb 9, 2021 08:32 AM Kindred Biosciences Announces Two New Appointments to Board of Directors

Dec 22, 2020 08:31 AM Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic Dermatitis

Dec 21, 2020 08:31 AM Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel Disease

Dec 11, 2020 08:00 AM Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody

Dec 11, 2020 08:00 AM Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market

Dec 2, 2020 04:02 PM Kindred Biosciences to Present at Guggenheim Animal Health Summit

Nov 11, 2020 08:32 AM Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium

Nov 9, 2020 04:02 PM Kindred Biosciences Announces Third Quarter 2020 Financial Results

Oct 28, 2020 04:05 PM Kindred Biosciences to Announce Third Quarter 2020 Financial Results

Oct 7, 2020 08:02 AM Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

Oct 7, 2020 08:00 AM Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

Sep 16, 2020 08:03 AM Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody

Sep 9, 2020 08:02 AM Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference

Aug 5, 2020 04:02 PM Kindred Biosciences Announces Second Quarter 2020 Financial Results

Jul 23, 2020 08:32 AM Kindred Biosciences to Announce Second Quarter 2020 Financial Results

Jun 8, 2020 04:02 PM Kindred Biosciences Announces Plan to Strengthen its Strategic Position

May 20, 2020 07:58 AM Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

May 13, 2020 08:30 AM Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference

May 7, 2020 04:02 PM Kindred Biosciences Announces First Quarter 2020 Financial Results

Apr 23, 2020 08:32 AM Kindred Biosciences to Announce First Quarter 2020 Financial Results

Apr 15, 2020 04:02 PM Kindred Biosciences Announces Completion of Mirataz® (mirtazapine transdermal ointment) Transaction

Mar 24, 2020 08:31 AM Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in Dogs

Mar 16, 2020 04:02 PM Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 3, 2020 04:02 PM Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results

Feb 18, 2020 08:30 AM Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit

Jan 8, 2020 04:02 PM Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies

Dec 16, 2019 08:02 AM Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs

Dec 12, 2019 09:05 AM Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight Loss

Nov 25, 2019 04:03 PM Kindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in Horses

Nov 14, 2019 04:05 PM Kindred Biosciences to Participate in Stifel Healthcare Conference and Jefferies London Healthcare Conference

Nov 12, 2019 04:01 PM Kindred Biosciences Announces Third Quarter 2019 Financial Results